The Latest
-
Ceribell wins FDA clearance for seizure-detection algorithm in neonates
By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 million market.
-
Okami raises $45M to commercialize vascular embolization devices
The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.
-
Abbott’s $21B Exact Sciences buy reveals future strategy
The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer testing.
-
GE HealthCare to buy Intelerad for $2.3B
GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal expands GE HealthCare’s presence in more outpatient settings.
-
Health tech venture capital investment rebounds in 2025: report
Funding through the third quarter surpassed last year’s total, according to PitchBook. Meanwhile, average deal sizes are skyrocketing as high valuations — especially for AI startups — drive larger rounds.
-
Solventum inks $725M Acera takeover
The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.
-
Q&A
Shockwave’s Nick West on shaking up treatment for blocked arteries
The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the pipeline in a conversation with MedTech Dive.
-
Abbott to acquire Exact Sciences for about $21B
The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early detection.
Updated Nov. 20, 2025 -
Roche inks deal for rights to Freenome cancer tests outside US
Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits, similar to with their prior success in IVD kits.”
-
Republican antipathy during key Senate hearing darkens outlook for ACA subsidy extension
More generous subsidies for Affordable Care Act plans have helped millions of Americans afford insurance. Chances are becoming slimmer that the assistance will survive the year.
-
Philips, Edwards team on AI-based guide for mitral valve repair
Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device during transcatheter heart procedures.